These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis. Kawai M; Hagihara K; Hirano T; Shima Y; Kuwahara Y; Arimitsu J; Narazaki M; Ogata A; Kawase I; Kishimoto T; Tanaka T Rheumatology (Oxford); 2009 Mar; 48(3):318-9. PubMed ID: 19106169 [No Abstract] [Full Text] [Related]
4. Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody. Emmrich J; Seyfarth M; Fleig WE; Emmrich F Lancet; 1991 Aug; 338(8766):570-1. PubMed ID: 1678821 [No Abstract] [Full Text] [Related]
5. Infliximab in a patient with refractory necrotizing scleritis associated with relapsing polychondritis. Jabbarvand M; Fard MA Ocul Immunol Inflamm; 2010 Jun; 18(3):216-7. PubMed ID: 20482401 [TBL] [Abstract][Full Text] [Related]
6. Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis. Prinz J; Braun-Falco O; Meurer M; Daddona P; Reiter C; Rieber P; Riethmüller G Lancet; 1991 Aug; 338(8762):320-1. PubMed ID: 1677143 [No Abstract] [Full Text] [Related]
7. Treatment of severe systemic lupus erythematosus with anti-CD4 monoclonal antibody. Hiepe F; Volk HD; Apostoloff E; von Baehr R; Emmrich F Lancet; 1991 Dec; 338(8781):1529-30. PubMed ID: 1683954 [No Abstract] [Full Text] [Related]
11. [Clinical analysis of 11 patients with relapsing polychondritis]. Huang Y; Mei J; Li Q; Cai C Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Jul; 23(14):625-7. PubMed ID: 19894551 [TBL] [Abstract][Full Text] [Related]
13. Clinical improvement of myasthenia gravis by treatment with a chimeric anti-CD4 monoclonal antibody. Ahlberg R; Yi Q; Pirskanen R; Matell G; Swerup C; Rieber P; Riethmüller G; Holm G; Lefvert AK Ann N Y Acad Sci; 1993 Jun; 681():552-5. PubMed ID: 8357195 [No Abstract] [Full Text] [Related]
14. Sustained response to etanercept after failing infliximab, in a patient with relapsing polychondritis with tracheomalacia. Subrahmanyam P; Balakrishnan C; Dasgupta B Scand J Rheumatol; 2008; 37(3):239-40. PubMed ID: 18465465 [No Abstract] [Full Text] [Related]
15. Prolonged response to anti-tumour necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis. Seymour MW; Home DM; Williams RO; Allard SA Rheumatology (Oxford); 2007 Nov; 46(11):1738-9. PubMed ID: 17933796 [No Abstract] [Full Text] [Related]
17. [Recurrent polychondritis. Presentation of two cases and a review of the literature]. Fliciński J; Brzosko M; Ostanek L; Płońska E; Cyryłowski L Pol Arch Med Wewn; 2004 Sep; 112(3):1093-9. PubMed ID: 15727091 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal anti-CD4 as immunoprophylactic agents for human immunodeficiency virus infection. Attanasio R; Allan JS; Kennedy RC J Infect Dis; 1993 Aug; 168(2):515-6. PubMed ID: 8335999 [No Abstract] [Full Text] [Related]
19. Relapsing polychondritis--treatment with cyclosporin A. Ormerod AD; Clark LJ Br J Dermatol; 1992 Sep; 127(3):300. PubMed ID: 1390179 [No Abstract] [Full Text] [Related]
20. Total hearing loss and blindness caused by relapsing polychondritis and myelodysplastic syndrome. Coha B; Fustar-Preradovic L; Sekelj S; Sekelj A Eur Arch Otorhinolaryngol; 2007 Dec; 264(12):1517-9. PubMed ID: 17639441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]